Attached files

file filename
10-K - FORM 10-K - FYE DEC 31 2013 - N-VIRO INTERNATIONAL CORPnvic10k2013.htm
EX-24.1 - EXHIBIT 24.1 - DIRECTOR POWER(S) OF ATTORNEY - N-VIRO INTERNATIONAL CORPnvic10k2013_ex24z1.htm
EX-31.2 - EXHIBIT 31.2 - CFO CERT - N-VIRO INTERNATIONAL CORPnvic10k2013_ex31z2.htm
EX-14.1 - EXHIBIT 14.1 - CODE OF ETHICS - N-VIRO INTERNATIONAL CORPnvic10k2013_ex14z1.htm
EX-21.1 - EXHIBIT 21.1 - LIST OF SUBSIDIARIES - N-VIRO INTERNATIONAL CORPnvic10k2013_ex21z1.htm
EX-31.1 - EXHIBIT 31.1 - CEO CERT - N-VIRO INTERNATIONAL CORPnvic10k2013_ex31z1.htm
EXCEL - IDEA: XBRL DOCUMENT - N-VIRO INTERNATIONAL CORPFinancial_Report.xls
EX-32.1 - EXHIBIT 32.1 - CEO SECTION 906 - N-VIRO INTERNATIONAL CORPnvic10k2013_ex32z1.htm
EX-32.2 - EXHIBIT 32.2 - CFO SECTION 906 - N-VIRO INTERNATIONAL CORPnvic10k2013_ex32z2.htm



Exhibit 23.1









CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-121439 and 333-36608) of our report dated June 2, 2014, relating to the consolidated financial statements of N-Viro International Corporation included in this Annual Report on Form 10-K for the years ended December 31, 2013 and 2012.


Our report described above contains an explanatory paragraph that states that the Company’s recurring losses, negative cash flow from operations and net working capital deficiency raise substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.  



/s/  UHY LLP

UHY LLP

Farmington Hills, Michigan

June 2, 2014